Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants.
Scott Wadler(Breast Center), Marshall S. Horwitz(University of Washington), Morris Edelman(Cohen Children's Medical Center), Alla M. Rozenblit(Yeshiva University), Della Makower, Ron Kaleya(Yeshiva University), Bo Yu(Cornell University), Elizabath Hyjek(Cornell University), Jian Tan(Fudan University), Maureen E. Lane(Cornell University)
PubMed
January 1, 2003
Cited by 33
Related Papers
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
|Pharmacological Reviews|2010|857
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
|Journal of Clinical Oncology|1997|652